BP1-7 MUC-1 peptide therapeutic vaccine: Began Phase I trial in Canada

Biomira Inc. (BIOMF), Edmonton, Alberta Product: BP1-7 MUC-1 peptide therapeutic vaccine Indication: Breast cancer Status: Began Phase I trial in Canada ...